The Progression of N6-methyladenosine Study and Its Role in Neuropsychiatric Disorders

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2022 Jun 10

PMID 35682599

Authors

Chunguang Lei

Qingzhong Wang

Affiliations

Soon will be listed here.

Abstract

Epitranscriptomic modifications can affect every aspect of RNA biology, including stability, transport, splicing, and translation, participate in global intracellular mRNA metabolism, and regulate gene expression and a variety of biological processes. N6-methyladenosine (m6A) as the most prevalent modification contributes to normal embryonic brain development and memory formation. However, changes in the level of m6A modification and the expression of its related proteins cause abnormal nervous system functions, including brain tissue development retardation, axon regeneration disorders, memory changes, and neural stem cell renewal and differentiation disorders. Recent studies have revealed that m6A modification and its related proteins play key roles in the development of various neuropsychiatric disorders, such as depression, Alzheimer's disease, and Parkinson's disease. In this review, we summarize the research progresses of the m6A modification regulation mechanism in the central nervous system and discuss the effects of gene expression regulation mediated by m6A modification on the biological functions of the neuropsychiatric disorders, thereby providing some insight into new research targets and treatment directions for human diseases.

Citing Articles

Surface Plasmon Resonance Imaging-Based Platform Enables Detection of Single, Site-Specific 5-Methylcytosine Associated with Post-traumatic Stress Disorder (PTSD).

Obliosca J, Vest O, Patel D, Ferguson T, Smith K, Christy D ACS Pharmacol Transl Sci. 2025; 8(2):522-532.

PMID: 39974633 PMC: 11833716. DOI: 10.1021/acsptsci.4c00628.

Esketamine alleviates depressive-like behavior in neuropathic pain mice through the METTL3-GluA1 pathway.

Ji X, Huang Z, Zhou C, Wang Y, Geng D, Zhang G Cell Biol Toxicol. 2025; 41(1):38.

PMID: 39875576 PMC: 11775062. DOI: 10.1007/s10565-024-09975-1.

The interplay between epitranscriptomic RNA modifications and neurodegenerative disorders: Mechanistic insights and potential therapeutic strategies.

Hashmi M, Fatima H, Ahmad S, Rehman A, Safdar F Ibrain. 2024; 10(4):395-426.

PMID: 39691424 PMC: 11649393. DOI: 10.1002/ibra.12183.

Enhancing m6A modification in the motor cortex facilitates corticospinal tract remodeling after spinal cord injury.

Qin T, Jin Y, Qin Y, Yuan F, Lu H, Hu J Neural Regen Res. 2024; 20(6):1749-1763.

PMID: 39104113 PMC: 11688564. DOI: 10.4103/NRR.NRR-D-23-01477.

Integration of multi-omics summary data reveals the role of N6-methyladenosine in neuropsychiatric disorders.

Liufu C, Luo L, Pang T, Zheng H, Yang L, Lu L Mol Psychiatry. 2024; 29(10):3141-3150.

PMID: 38684796 DOI: 10.1038/s41380-024-02574-w.

References

Morgan M, Shilatifard A . Reevaluating the roles of histone-modifying enzymes and their associated chromatin modifications in transcriptional regulation. Nat Genet. 2020; 52(12):1271-1281. DOI: 10.1038/s41588-020-00736-4. View

Patil D, Chen C, Pickering B, Chow A, Jackson C, Guttman M . m(6)A RNA methylation promotes XIST-mediated transcriptional repression. Nature. 2016; 537(7620):369-373. PMC: 5509218. DOI: 10.1038/nature19342. View

Bird A . Molecular biology. Methylation talk between histones and DNA. Science. 2001; 294(5549):2113-5. DOI: 10.1126/science.1066726. View

Hsu P, Zhu Y, Ma H, Guo Y, Shi X, Liu Y . Ythdc2 is an N-methyladenosine binding protein that regulates mammalian spermatogenesis. Cell Res. 2017; 27(9):1115-1127. PMC: 5587856. DOI: 10.1038/cr.2017.99. View

Zhang Z, Wang M, Xie D, Huang Z, Zhang L, Yang Y . METTL3-mediated N-methyladenosine mRNA modification enhances long-term memory consolidation. Cell Res. 2018; 28(11):1050-1061. PMC: 6218447. DOI: 10.1038/s41422-018-0092-9. View

Squires J, Patel H, Nousch M, Sibbritt T, Humphreys D, Parker B . Widespread occurrence of 5-methylcytosine in human coding and non-coding RNA. Nucleic Acids Res. 2012; 40(11):5023-33. PMC: 3367185. DOI: 10.1093/nar/gks144. View

Wang Y, Li Y, Yue M, Wang J, Kumar S, Wechsler-Reya R . N-methyladenosine RNA modification regulates embryonic neural stem cell self-renewal through histone modifications. Nat Neurosci. 2018; 21(2):195-206. PMC: 6317335. DOI: 10.1038/s41593-017-0057-1. View

Li A, Chen Y, Ping X, Yang X, Xiao W, Yang Y . Cytoplasmic mA reader YTHDF3 promotes mRNA translation. Cell Res. 2017; 27(3):444-447. PMC: 5339832. DOI: 10.1038/cr.2017.10. View

Liu S, Xiu J, Zhu C, Meng K, Li C, Han R . Fat mass and obesity-associated protein regulates RNA methylation associated with depression-like behavior in mice. Nat Commun. 2021; 12(1):6937. PMC: 8626436. DOI: 10.1038/s41467-021-27044-7. View

10.

Dixit D, Prager B, Gimple R, Poh H, Wang Y, Wu Q . The RNA m6A Reader YTHDF2 Maintains Oncogene Expression and Is a Targetable Dependency in Glioblastoma Stem Cells. Cancer Discov. 2020; 11(2):480-499. PMC: 8110214. DOI: 10.1158/2159-8290.CD-20-0331. View

11.

Li M, Zhao X, Wang W, Shi H, Pan Q, Lu Z . Ythdf2-mediated mA mRNA clearance modulates neural development in mice. Genome Biol. 2018; 19(1):69. PMC: 5984442. DOI: 10.1186/s13059-018-1436-y. View

12.

Wang P, Doxtader K, Nam Y . Structural Basis for Cooperative Function of Mettl3 and Mettl14 Methyltransferases. Mol Cell. 2016; 63(2):306-317. PMC: 4958592. DOI: 10.1016/j.molcel.2016.05.041. View

13.

Haley B, Paunesku T, Protic M, Woloschak G . Response of heterogeneous ribonuclear proteins (hnRNP) to ionising radiation and their involvement in DNA damage repair. Int J Radiat Biol. 2009; 85(8):643-55. PMC: 2785495. DOI: 10.1080/09553000903009548. View

14.

Meyer K, Jaffrey S . The dynamic epitranscriptome: N6-methyladenosine and gene expression control. Nat Rev Mol Cell Biol. 2014; 15(5):313-26. PMC: 4393108. DOI: 10.1038/nrm3785. View

15.

Zhang C, Jia G . Reversible RNA Modification N-methyladenosine (mA) in mRNA and tRNA. Genomics Proteomics Bioinformatics. 2018; 16(3):155-161. PMC: 6076376. DOI: 10.1016/j.gpb.2018.03.003. View

16.

Visvanathan A, Patil V, Arora A, Hegde A, Arivazhagan A, Santosh V . Essential role of METTL3-mediated mA modification in glioma stem-like cells maintenance and radioresistance. Oncogene. 2017; 37(4):522-533. DOI: 10.1038/onc.2017.351. View

17.

Peters T, Ausmeier K, Ruther U . Cloning of Fatso (Fto), a novel gene deleted by the Fused toes (Ft) mouse mutation. Mamm Genome. 1999; 10(10):983-6. DOI: 10.1007/s003359901144. View

18.

Frayling T, Timpson N, Weedon M, Zeggini E, Freathy R, Lindgren C . A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science. 2007; 316(5826):889-94. PMC: 2646098. DOI: 10.1126/science.1141634. View

19.

Wang X, He C . Reading RNA methylation codes through methyl-specific binding proteins. RNA Biol. 2014; 11(6):669-72. PMC: 4156498. DOI: 10.4161/rna.28829. View

20.

Zhu T, Roundtree I, Wang P, Wang X, Wang L, Sun C . Crystal structure of the YTH domain of YTHDF2 reveals mechanism for recognition of N6-methyladenosine. Cell Res. 2014; 24(12):1493-6. PMC: 4260350. DOI: 10.1038/cr.2014.152. View